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Abstract Insect acetylcholinesterase, an enzyme whose catalyt-
ic site is located at the bottom of a gorge, can metabolise its
substrate in a wide range of concentrations (from 1 WM to 200
mM) since it is activated at low substrate concentrations. It also
presents inhibition at high substrate concentrations. Among the
various rival kinetic models tested to analyse the kinetic
behaviour of the enzyme, the simplest able to explain all the
experimental data suggests that there are two sites for substrate
molecules on the protein. Binding on the catalytic site located at
the bottom of the gorge seems to be irreversible, suggesting that
each molecule of substrate which enters the active site gorge is
metabolised. Reversible binding at the peripheral site of the free
enzyme has high affinity (2 WM), suggesting that this binding
increases the probability of the substrate entering the active site
gorge. Peripheral site occupation decreases the entrance rate
constant of the second substrate molecule to the catalytic site and
strongly affects the catalytic activity of the enzyme. On the other
hand, catalytic site occupation lowers the affinity of the
peripheral site for the substrate (34 mM). These effects between
the two sites result both in apparent activation at low substrate
concentration and in general inhibition at high substrate
concentration.
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1. Introduction
Cholinesterases are serine hydrolases which have been di-
vided into two classes, acetylcholinesterase (AChE, EC 3.1.1.7)
and butyrylcholinesterase (EC 3.1.1.8) according to their cat-
alytic properties, inhibition speci¢cities and tissue distribution
(for a review of cholinesterases, see MassoulieŁ et al. [1]). Two
substrate binding sites are present on each monomer: a cata-
lytic site which lies at the bottom of a 20 Aî deep gorge, and a
peripheral anionic site represented by some of the numerous
aromatic residues at the rim of the active site gorge. The
catalytic site is composed of two subsites: a catalytic ‘anionic’
site which recognises the choline moiety of the substrate, and
an ‘esteratic’ site responsible for the hydrolysis of the sub-
strate. The hydrolysis is described as occurring in three steps:
(a) reversible Michaelis complex formation, (b) acylation of
the enzyme and (c) deacylation induced by a water molecule
[2^5].
Most cholinesterases, from di¡erent sources, do not follow
Michaelis-Menten kinetics: vertebrate butyrylcholinesterase
displays activation at low substrate concentration and verte-
brate acetylcholinesterase displays an inhibition by an excess
of substrate. Two main hypotheses have been proposed to
explain these kinetics. The ¢rst assumes a modulation of the
deacylation rate constant by the binding of an additional sub-
strate molecule on the acyl-enzyme intermediate [6] and the
second hypothesis involves the non-competitive binding of the
substrate to a peripheral site, increasing or decreasing the
catalytic ability of the enzyme [7]. Insect cholinesterase ki-
netics which combine activation and inhibition [8] cannot be
analysed by such models. Thus, we propose a putative kinetic
model, with a reasonable number of parameters, able to de-
scribe the complex kinetics of insect AChE.
2. Materials and methods
2.1. Source of enzyme
A truncated cDNA encoding a soluble AChE of Drosophila mela-
nogaster was expressed with the baculovirus system [9]. Secreted
AChE was puri¢ed and stabilised with 1 mg/ml BSA according to
Estrada-Mondaca and Fournier [10].
2.2. Kinetics of substrate hydrolysis
Kinetics were studied at 25‡C in 25 mM phosphate bu¡er pH 7.
Hydrolysis of thiocholine iodide esters was followed spectrophotomet-
rically at 412 nm using the method of Ellman et al. [11] at substrate
concentrations from 1 WM to 200 mM. Active site titration was car-
ried out using 7-(methylethoxy phosphinyloxy)-1-methylquinolinium
iodide which was synthesised as described by Levy and Ashani [12].
2.3. Data analysis
The initial rate constants were analysed according to mathematical
models which result from di¡erent kinetic mechanisms, using a non-
linear regression program [13]. Discriminations between the di¡erent
models tested were made according to general criteria for goodness of
¢t [14].
3. Results and discussion
3.1. Choice of the kinetic model
From the complex kinetic behaviour of Drosophila AChE,
three main hypotheses can be suggested: (1) two kinetically
distinct enzymatic forms or two enzymatic forms in equilib-
rium are present; (2) one enzymatic form with three sub-
strate binding sites ; (3) one enzymatic form with two sub-
strate binding sites. For each hypothesis, we deduced
di¡erent plausible kinetic schemes. In order to have a reason-
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able number of parameters, di¡erent simpli¢cations were
made, for example, inclusion of formation of the Michaelian
complex and acylation in the same step, or inclusion of acy-
lation and deacylation in the same step. From these schemes,
kinetic equations were derived and used to analyse initial rate
constants by non-linear regression.
It appeared evident that models with three binding sites or
with two independent enzyme species were appropriate to
resolve data sets. But since (i) docking assays of three sub-
strate molecules on the active site failed due to the narrowness
of the active site gorge, (ii) we were unable to characterise two
enzymatic forms and (iii) all known post-translational modi-
¢cations of the enzyme did not change the kinetic behaviour
[15], we excluded such schemes and we considered only mod-
els with one enzymatic form and two substrate binding sites.
From this assumption, the model presented in Scheme 1
appeared to be appropriate. It was functional for all sets of
data obtained in several conditions (pH, temperature), with
di¡erent mutated enzymes on amino acids lining the active
site gorge (Fig. 1), with di¡erent substrates (Fig. 2) or in
the presence of reversible inhibitors (in this latter case, param-
eters describing the binding of inhibitor molecules on each
enzymatic complex were added).
3.2. Signi¢cance of the model
Although other models may also be adequate and although
it is speculative to describe the biological functioning of an
enzyme from pS curves only, we tried to evaluate the signi¢-
cance of this model.
The main point is that the formation of the complex ES is
an irreversible step. This irreversibility, as implied by the mod-
el, seems to corroborate structural information. Indeed, asym-
metric charge distribution of the enzyme suggests that every
substrate molecule that encounters the entrance of the active
site gorge proceeds to reaction. An electrostatic gradient at-
tracts the substrate inside the gorge, where it is blocked and
most probably metabolised [16,17]. To analyse this hypothe-
sis, we performed a dynamic simulation with the Drosophila
active site gorge deduced from the Torpedo enzyme coordi-
nates [4]. The tetrahedral intermediate was minimised in the
active site to mimic the substrate positioning in the Michae-
lian complex. It seems that the choline part is enclosed in a
box composed of four aromatic residues at positions 330, 334,
331 and 84 (Torpedo numbering) which form an aromatic cage
[18]. This arrangement could hinder substrate exit from the
gorge and explain the apparent irreversibility of ES complex
formation.
The second point is the presence of a non-productive site.
Such a site has already been described in vertebrate enzymes,
is usually called a peripheral anionic site and is located at the
rim of the active site gorge [19]. The model also assumes the
presence of this site in insect AChE. But, in contrast to pre-
vious models [7,20], the a⁄nity of this site for the substrate is
very high (2 WM). We can hypothesise that this high a⁄nity
allows substrate molecules to be trapped at the entrance of the
active site gorge, locally increasing the substrate concentration
and hence the probability of the substrate entering and reach-
ing the active site. The a⁄nity of the peripheral site changes
according to the enzyme form: the high substrate a⁄nity for
the peripheral anionic site on the free enzyme is strongly re-
duced (V4 orders of magnitude) by the presence of substrate
at the catalytic site (34 mM). To explain this variation of
a⁄nity of the peripheral site when the catalytic site is occu-
pied, one hypothesis can be expressed: the arrangement of the
aromatic residues at the catalytic site around the choline moi-
ety of the substrate changes the arrangement of aromatic res-
idues located at the rim of the gorge, and thus the putative
peripheral site.
The third point is the e¡ect of peripheral site occupation on
the entrance of a new molecule inside the gorge. This e¡ect is
represented by the b factor, which, with Ks, is responsible for
the apparent activation observed in the insect AChE (Fig. 3).
The b factor is less than 1 (see Table 1) which indicates that
the entering of a substrate molecule into the gorge and/or the
positioning at the catalytic site are slowed down by a sub-
strate molecule bound to the rim of the gorge, most probably
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Scheme 1. General model for activation and inhibition of Drosophila
AChE depending on substrate concentration. E is the free enzyme,
ES is a Michaelian complex representing the binding of a substrate
molecule onto the catalytic site and SE represents the binding of a
substrate molecule onto the peripheral site.
Fig. 1. pS activity curves for acetylthiocholine hydrolysis by wild
type Drosophila acetylcholinesterase, W279L and F78S mutants
(Torpedo numbering). The curves were obtained by ¢tting to the
equation in Scheme 1. Parameter values are presented in Table 1.
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by steric interactions. This e¡ect has recently been described
for some ligands [21].
Finally, binding of a substrate molecule at the peripheral
site decreases the metabolisation of the substrate at the bot-
tom of the gorge (a6 1), resulting in the inhibition of the
enzyme (Fig. 3). At very high substrate concentrations, the
molecule binds at the peripheral anionic site even if another
substrate molecule is present at the active site, but with very
low a⁄nity. This binding greatly hinders the metabolisation of
a new substrate molecule and so results in a general inhibition
of the enzyme. This inhibition of the catalytic step may re£ect
either jam in the tra⁄c between substrate molecules and prod-
ucts circulating in the gorge or a direct e¡ect on the position-
ing of the substrate molecule at the catalytic site as previously
suggested by the change of peripheral site a⁄nity when the
catalytic site is occupied.
This model was deduced from pS curves obtained with the
Drosophila enzyme. If it is applied to vertebrate enzymes, the
lack of one phase, i.e. activation in AChE or inhibition in
butyrylcholinesterase, may be explained either by the fact
that these phases do not exist in these enzymes or because
one phase is masked. In vitro mutagenesis sometimes produ-
ces enzymes which reveal both phases: activation and inhib-
ition [22], so the second possibility appears plausible. In ver-
tebrate enzymes or in mutant enzymes in which the activation
phase is lacking, this could be due to a lower a⁄nity for the
peripheral site or to lack of e¡ect of peripheral site occupation
on the entrance to the catalytic site. Absence of inhibition at
high substrate concentrations may only indicate that the value
of Ks is higher than the substrate solubility in aqueous solvent
and so was undetectable (Fig. 3).
3.3. Has the complex behaviour of cholinesterase any
physiological signi¢cance?
The activation of the enzyme depending on substrate con-
centration may serve to adjust the catalytic activity to £uctu-
ations in the concentration of the neurotransmitter, following
its release in the synaptic cleft. The peripheral site would act
as a sensor allowing substrate molecules to be caught but only
when present at low concentrations and may serve to control
the neurotransmitter concentration in the synaptic cleft. It is
believed that acetylcholine is released in the synapse in a con-
centration range of 0.1^1 mM [23] which corresponds to the
maximal activity of the enzyme. After its release, the neuro-
transmitter binds to the receptor and is simultaneously metab-
olised by AChE. It should be noted that the receptor exists in
two states (resting and desensitised) and has two binding sites
for acetylcholine resulting in di¡erent a⁄nities for acetylcho-
line, from 1033 to 1039 M. Thus, ligand concentration be-
tween two pulses determines the relative concentration of rest-
ing and desensitised receptors and consequently, the response
to the subsequent pulse [24]. Thus, allostery in AChE seems to
be correlated to receptor function; the combination of the two
kinetics allows the response to successive nerve impulses. In-
hibition at high substrate concentration is puzzling, but these
concentrations are not likely to occur under physiological
conditions except following organophosphorus compound in-
toxication. Nevertheless, we suggest here that activation and
inhibition originate from the same interaction between the
catalytic site and the peripheral site and that the inhibition
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Table 1
Kinetic parameters obtained by data analysis with the equation in Scheme 1, for the wild type Drosophila enzyme and mutant enzymes W279L
and Y78F (Torpedo numbering)
Enzyme Wild type Wild type Wild type W279L F78S
Substrate ATCh ALMeTCh BuTCh ATCh ATCh
Ks (WM) 2 55 6 8 12
KPs (mM) 34 4 9 22 43
kcat (s31) 986 1166 611 991 696
k2 (WM31 s31) 133 36 18 77 8.5
a 0.06 0.20 0.36 0.06 0.018
b 0.15 0.19 0.28 0.01 0.31
Fig. 2. pS activity curves for acetylthiocholine (ATCh), acetyl-L-
methylthiocholine (ALMeTCh) and butyrylthiocholine (BuTCh) hy-
drolysis by wild type Drosophila AChE. The curves were obtained
by ¢tting to the equation in Scheme 1. Parameters values are pre-
sented in Table 1.
Fig. 3. Curves generated using the equation in Scheme 1 and the
parameters of Table 1 (wild type/ATCh). Some parameters were
modi¢ed to show their in£uence on the Drosophila AChE kinetics.
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by excess substrate is a consequence of the peripheral site
saturation.
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